| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/23/2013 | CN102885973A Chinese medicinal decoction for treating hypertension |
| 01/23/2013 | CN102885972A Chinese medicinal composition for reducing blood pressure and application method thereof |
| 01/23/2013 | CN102885971A Chinese herbal medicine decoction for treating hemorrhoids and preparation method thereof |
| 01/23/2013 | CN102885959A Method for preparing garlicin and application of garlicin |
| 01/23/2013 | CN102885957A Traditional Chinese medicine composition for preventing and treating hypertension and preparation method thereof |
| 01/23/2013 | CN102885945A External traditional Chinese medicine composition for treating haemorrhoids and preparation method of external traditional Chinese medicine composition |
| 01/23/2013 | CN102885940A Chinese medicinal blood-pressure-lowering medicinal liquor |
| 01/23/2013 | CN102885935A Production technology of cephalocathartic hypertension particles |
| 01/23/2013 | CN102885925A Chinese medicinal preparation for treating deficiency of qi and blood, qi stagnation and blood stasis |
| 01/23/2013 | CN102885903A Medicine for treating stroke |
| 01/23/2013 | CN102885898A Preparation for treating heart disease and method for preparing same |
| 01/23/2013 | CN102885896A Medicine for treating thromboangitis obliterans |
| 01/23/2013 | CN102885893A Pharmaceutical composition for treating haemorrhoids |
| 01/23/2013 | CN102885888A Method for preparing salvia miltiorrhiza injection |
| 01/23/2013 | CN102885886A Component extraction and impurity removal method of salvianolic acids |
| 01/23/2013 | CN102885885A Health-care oral liquid for preventing and treating hypertension |
| 01/23/2013 | CN102885868A Novel application of Pien Tze Huang and preparation of Pien Tze Huang to protection of memory function and resistance of cerebral ischemia |
| 01/23/2013 | CN102885863A Flavone hippophae composition and application of composition |
| 01/23/2013 | CN102885838A Novel use of catalpol in preparation of drug for treating cerebral arterial thrombosis reperfusion injuries |
| 01/23/2013 | CN102885836A Application of Gypensapogenin B in medicament for treating or preventing acute heart failure |
| 01/23/2013 | CN102885827A Application of Gypensapogenin A to preparation of drug for preventing or treating chronic heart failure |
| 01/23/2013 | CN102885824A Application of Gypensapogenin A in medicament for treating ischemic brain injury |
| 01/23/2013 | CN102885823A Stable pharmaceutical composition containing sodium tanshinone IIA sulfonate |
| 01/23/2013 | CN102885810A Candesartan cilexetil double-release capsule and preparation method thereof |
| 01/23/2013 | CN102885795A Trimetazidine dihydrochloride sustained-release tablet and preparation method thereof |
| 01/23/2013 | CN102885789A Preparation method of compound preparation for treating high blood pressure |
| 01/23/2013 | CN102885780A Method for improving bioavailability of resveratrol |
| 01/23/2013 | CN102885346A Wheat, jujube and rose beverage for nourishing heart and soothing nerves and preparation method thereof |
| 01/23/2013 | CN102525909B Method for preparing penehyclidine hydrochloride injection |
| 01/23/2013 | CN102397265B Method for preparing sinomenine hydrochloride membrane-controlled enteric controlled-release tablet |
| 01/23/2013 | CN102327265B Amlodipine and olmesartan medoxomil pharmaceutical composition and preparation method thereof |
| 01/23/2013 | CN102319401B Traditional Chinese medicine composition for tonifying qi and invigorating blood circulation, invigorating spleen and dredging collaterals |
| 01/23/2013 | CN102319399B Traditional Chinese medicine composition used for treating coronary heart disease and cerebral arteriosclerosis, and preparation method thereof |
| 01/23/2013 | CN102319331B Medicine for removing necrotic tissue and promoting granulation |
| 01/23/2013 | CN102319268B Preparation method of injection used for treating chronic congestive cardiac failure |
| 01/23/2013 | CN102240343B Environment-friendly preparation method for high-ester catechin tea polyphenol |
| 01/23/2013 | CN102178761B Traditional Chinese medicine for treating hypertension and hypotension |
| 01/23/2013 | CN102119926B Valsartan self-emulsifying medicament transfer system and preparation method thereof |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101979402B Marine cyclic peptide compound and preparation method and use thereof |
| 01/23/2013 | CN101926841B Total flavonoids of herba lycopi in botanical medicine for treating cardiovascular disease and preparation method thereof |
| 01/23/2013 | CN101816701B Process for preparing kudzu root extract instant grains |
| 01/23/2013 | CN101797375B Application of MG53 protein for preventing and/or treating myocardial ischemia/reperfusion injury |
| 01/23/2013 | CN101791309B Oral solid preparation containing clopidogrel hydrogen sulfate |
| 01/23/2013 | CN101735918B Selenium-rich health wine and production method thereof |
| 01/23/2013 | CN101721430B Application of amniotic epithelial cells in pharmacy |
| 01/23/2013 | CN101698031B Method for separating short-tube lycoris total alkaloids by ion exchange resin |
| 01/23/2013 | CN101657192B Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/23/2013 | CN101607907B Substituted benzoic acid derivative and synthesizing method thereof and application thereof |
| 01/23/2013 | CN101417005B Gentian bitterness concealing technique in oral liquid |
| 01/23/2013 | CN101314045B Sulphur butyl ether-beta-cyclodextrin clathrate compound of cinnarizine, formulated product and preparation method thereof |
| 01/23/2013 | CN101314000B Gastrodia tuber eucommia health care capsule and preparation method thereof |
| 01/22/2013 | US8357704 Fused heterocyclic compounds as inhibitors of potassium channel function |
| 01/22/2013 | US8357674 Analogues of cilostazol |
| 01/22/2013 | CA2648751C Use of aminapthone for the preparation of a medicament for treating arteriopathies |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/17/2013 | WO2013010034A2 Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers |
| 01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | WO2013008928A1 Macrolide derivative |
| 01/17/2013 | WO2013008881A1 Ischemic disease therapeutic agent |
| 01/17/2013 | WO2013008872A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | WO2013008175A1 Method for producing trans-resveratrol and the analogs thereof |
| 01/17/2013 | WO2013008164A2 Method of treating atherosclerosis in high triglyceride subjects |
| 01/17/2013 | WO2013007766A1 Means and methods for the treatment of pathological angiogenesis |
| 01/17/2013 | WO2013007725A2 Aliskiren hemifumarate, crystal form and amorphous solid |
| 01/17/2013 | WO2013007663A1 2-benzylsulfanyl[1,3,4]-oxadiazole derivatives, and medical use thereof |
| 01/17/2013 | WO2013007519A1 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | WO2013007518A1 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | WO2013007092A1 Medicament for treatment of coronary heart diseases and angina pectoris and preparation method therefor |
| 01/17/2013 | WO2012157980A3 Manufacturing method of azilsartan |
| 01/17/2013 | WO2012157977A3 Manufacturing method of heterocyclic compound |
| 01/17/2013 | WO2012148200A3 Composition for aiding surgical procedures for treating ischemic vascular diseases |
| 01/17/2013 | WO2012146724A3 Novel rock inhibitors |
| 01/17/2013 | WO2011157908A8 Use of the combination of an inhibitor of the if current of the sinoatrial node and an inhibitor of the angiotensin-converting enzyme for treating heart failure |
| 01/17/2013 | US20130018299 Nanoshells on polymers |
| 01/17/2013 | US20130018101 Salts of fenofibric acid and pharmaceutical formulations thereof |
| 01/17/2013 | US20130018093 Novel epoprostenol formulation and method of making thereof |
| 01/17/2013 | US20130018084 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 01/17/2013 | US20130018074 New compounds |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018066 Heterocyclic aspartyl protease inhibitors |
| 01/17/2013 | US20130018065 Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 01/17/2013 | US20130018063 Organic compounds |
| 01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018043 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 01/17/2013 | US20130018019 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity |
| 01/17/2013 | US20130018017 Quinolinone derivatives as parp and tank inhibitors |
| 01/17/2013 | US20130018014 New class of therapeutics that enhance small molecule diffusion |
| 01/17/2013 | US20130018006 Atheroscleroclastic Bioceutical Formulations |
| 01/17/2013 | US20130018005 Glycoside derivatives and uses thereof |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |